Trial site
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
- 19running trials
- 6closed trials
The trials here
What the 25 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Liver and biliary tract cancer3 trials
- Gastric and oesophageal cancer2 trials
- Multiple myeloma2 trials
- Myeloproliferative neoplasms2 trials
- Asthma1 trial
- Cervical cancer1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Head and neck cancer1 trial
- Mantle cell lymphoma1 trial
- Multiple sclerosis1 trial
- and 2 more
- Phase
- Phase 37 trials
- Phase 16 trials
- Phase 25 trials
- Phase 1/22 trials
- Phase 2/31 trial
- Status
- Recruiting9 trials
- Not yet recruiting8 trials
- Completed5 trials
- Active, not recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.3 trials
- Shanghai Henlius Biotech3 trials
- Daishi Tian2 trials
- Dizal Pharmaceuticals2 trials
- Hoffmann-La Roche2 trials
- and 13 more
Running trials
Recruiting
Recruiting
Not yet recruiting
Universal STAR-T Cell Injection in Generalized Myasthenia Gravis
Recruiting
Recruiting
Not yet recruiting
Not yet recruiting
A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis.
Recruiting
Recruiting
Recruiting
Not yet recruiting
Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC
Recruiting
Recruiting
ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Liver and biliary tract cancer3 recruiting
- Myeloproliferative neoplasms2 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Multiple myeloma1 recruiting
- Multiple sclerosis1 recruiting
- Myasthenia gravis1 recruiting
Closed trials
Completed
Completed
Terminated
TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026